2 months Evolent Health (NYSE:EVH) Price Target Lowered to $33.00 at Citigroup MarketBeat
Citigroup decreased their target price on Evolent Health from $35.00 to $33.00 and set a “buy” rating on the stock in a research note on Tuesday.
Citigroup (C) · Health · NYSE · Science
X